REGULATORY AFFAIRS
Revive pharmaceutical PSUs for large-scale production of generic medicines: Parliamentary panel
NEW DELHI: A parliamentary committee has suggested revival of pharmaceutical public sector undertakings like HAL and IDPL for large scale production of affordable generic medicines to be provided to common man.
The committee, which was chaired by BJP member Shanta Kumar, also felt the need to investigate the reasons behind the poor performance and near closure of PSU's and to ensure that resources are utilised in the appropriate manner. Economic Times
News Must Read
- NCL General Manager (Finance) D Sunil Kumar recommended for SECL Director (Finance)
- Bank of Maharashtra Q4 results, Net Profit increased by 44.95 percent to Rs 1,218 crore
- Axis Bank Overtakes Kotak Mahindra Bank to Become India's Fourth Most Valued Lender
- LIC cuts stakes in major PSU stocks
- SJVN CMD Geeta Kapur Inaugurates Construction Works at Sunni Dam Project in Himachal Pradesh
- PESB Selects R Veerabahu as Director (Finance) for Braithwaite & Co. Limited
- Grew Energy bags largest order of 200 MW Contract of SECI's Auction
- CPCL Reports 39% YoY Drop in Q4 Net Profit, Declares Rs 55 per Share Dividend
- SJVN Limited inaugurates India's first Multi-purpose Green Hydrogen Pilot Project
- KRDCL, RVNL JV emerges as the Lowest Bidder for Redevelopment of Thiruvananthapuram Central Railway Station